Needham & Company
-
Lucid Diagnostics Inc (LUCD) PT Lowered to $7 at Needham & Company
-
Lucid Diagnostics to Participate in a Fireside Chat at the 24th Annual Needham Virtual Growth Conference
-
Lucid Diagnostics Inc (LUCD) PT Lowered to $13 at Needham & Company
-
UPDATE: Needham & Company Starts Lucid Diagnostics Inc (LUCD) at Buy
-
Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
-
Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
-
Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
-
Lucid Diagnostics (LUCD) IPO Opens, Trades Lower
-
Lucid Diagnostics Inc (LUCD) Prices 5M Share IPO at $14/sh
-
Lucid Diagnostics Announces Pricing of Initial Public Offering
-
Lucid Diagnostics Announces Pricing of Initial Public Offering
-
Lucid Diagnostics Announces Pricing of Initial Public Offering
-
Lucid Diagnostics (LUCD) IPO: 7 Things to Know